Zobrazeno 1 - 10
of 144
pro vyhledávání: '"S. Fragoso"'
Autor:
Renata M. F. Mélo, Rafaela S. Barbosa, Victória L. Ozório, Gabriel M. Oliveira, Samuel I. M. Horita, Andrea Henriques-Pons, Tânia C. Araújo-Jorge, Viviane M. S. Fragoso
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Stress is the body’s physiological reaction to a dangerous or threatening situation, leading to a state of alertness. This reaction is necessary for developing an effective adaptive response to stress and maintaining the body’s homeostasis. Chron
Externí odkaz:
https://doaj.org/article/7ffc744e047446659a68ac3ed5522de2
Autor:
Renata M. Felippe, Gabriel M. Oliveira, Rafaela S. Barbosa, Betina D. Esteves, Beatriz M. S. Gonzaga, Samuel I. M. Horita, Luciana R. Garzoni, Daniela G. Beghini, Tânia C. Araújo-Jorge, Viviane M. S. Fragoso
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 15 (2021)
Aggression is defined as hostile behavior that results in psychological damage, injury and even death among individuals. When aggression presents itself in an exacerbated and constant way, it can be considered escalating or pathological. The associat
Externí odkaz:
https://doaj.org/article/036301955e594371b6090ff1dfcc87ce
Autor:
Viviane M S Fragoso
Publikováno v:
American Journal of Biomedical Science & Research. 15:444-451
Publikováno v:
Lupus
Background Patients with chronic diseases are potential candidates for inadequate follow-up of drug therapy, tending to incur damage to the intended results. This deserves greater attention in the pandemic period, as they are in the considered risk g
Autor:
Fátima Vaz, Catarina Bexiga, Cecília Moura, J. Parreira, Pedro Louro, S. Bento, Patrícia Pereira, I.C. Oliveira, Priscila Nejo, Ana Clara, S. Santos, Paula Rodrigues, A. Luís, Alexandra Mayer, S. Fragoso, I. Miguel
Publikováno v:
Cancer Research. 80:P6-08
PURPOSERecent studies questioned the role of BRCA2 as a prognostic factor. Although differences between clinicopathological characteristics of BRCA1-breast cancer (BC) and BRCA2-BC have been described, long-term follow-up data related to prognosis an
Autor:
Priscila Nejo, S. Fragoso, Catarina Bexiga, Ana T. Luís, Ana Clara, Pedro Louro, Fátima Vaz, Conceição Souto Moura, S. Santos, Alexandra Mayer
Publikováno v:
Cancer Research. 80:P6-08
PURPOSE Previous studies referred to uptake of preventive surgeries (PS) in BRCA1/2 healthy carriers in ages older than recommended (35yrs). Since our population has a higher prevalence of BRCA2 mutations (usually associated with an older age at Brea
Autor:
Paula Rodrigues, P. Machado, Fátima Vaz, F. Rodrigues, S. Bento, A. Opinião, S. Fragoso, Ana Clara, I. Coelho, VL Gomes, J. Parreira, S. Santos, Ana T. Luís
Publikováno v:
Cancer Research. 79:P5-09
INTRODUTION: Considered a medium penetrance gene, CHEK2 codes for a kinase that is a key component of the DNA damage-signaling pathway. CHEK2 pathogenic variants were previously associated with breast and colorectal families and also with Li-Fraumeni
Autor:
P. Freitas, M. Melo, A. Luis, S. Bento, S. Fernandes, S. Santos, S. Fragoso, T. Duarte, P. Rodrigues, F. Vaz, I. Miguel
Publikováno v:
Annals of Oncology. 33:S342
Autor:
P. Antunes Meireles, I. Miguel, S. Fragoso, S. Santos, Paula Rodrigues, Beatriz Mira, I.C. Oliveira, A. Opinião, A.C. Luís, T. Duarte, Fátima Vaz, C. Pereira
Publikováno v:
Annals of Oncology. 32:S751-S752
Autor:
Beatriz Mira, Catarina Cardoso, A. Opinião, I.C. Oliveira, S. Fragoso, António Guimarães, Fátima Vaz
Publikováno v:
Gynecologic Oncology. 162:S259-S260
Objectives: In clinical trials maintenance treatment with PARP inhibitors (PARPi) improved progression-free survival with manageable toxicity in platinum-sensitive recurrent ovarian cancer (PSROC). In this study we review the impact of olaparib (reim